InnoCan Pharma Corporation

INNO.CNCNQHealthcare● Active

$3.40

$-0.20(-5.56%)

Market Cap$15295818

P/E Ratio—

52W High$21

52W Low$3.01

Avg Volume828

Open$3.40

Beta-0.27

Earnings Financials Revenue

InnoCan Pharma Corporation (INNO.CN) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

INNO.CN · earnings · updated Jun 10, 2026

Latest Earnings

Q1 FY2026Report Date: Mar 31, 2026

EPS Actual

-$0.31

Revenue

$0.01B

Fiscal Period

Q1 FY2026

FY ends December

Report Date

Mar 31, 2026

After Market Close

INNO.CN reports quarterly as a CNQ-listed Drug Manufacturers - Specialty & Generic company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Next earnings date not yet announced.

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2026	May 27, 2026	—	—	—	—	—	—
— Q1 FY2026	Mar 31, 2026	—	-$0.31	—	$0.01B	—	—
— Q3 FY2023	Sep 30, 2023	—	-$0.01	—	$0.00B	—	—
— Q2 FY2023	Jun 30, 2023	—	-$0.00	—	$0.00B	—	—
— Q1 FY2023	Mar 31, 2023	—	-$0.00	—	$0.00B	—	—
— Q4 FY2022	Dec 31, 2022	—	-$0.00	—	$0.00B	—	—

Q2 FY2026

May 27, 2026

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q1 FY2026

Mar 31, 2026

EPS Actual

-$0.31

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q3 FY2023

Sep 30, 2023

EPS Actual

-$0.01

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2023

Jun 30, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q1 FY2023

Mar 31, 2023

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2022

Dec 31, 2022

EPS Actual

-$0.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for INNO.CN.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q1 FY2026	Mar 31, 2026	—	$6.59	$6.66	+1.06%
— Q3 FY2023	Sep 30, 2023	—	$20.15	$21.78	+8.09%
— Q2 FY2023	Jun 30, 2023	—	$15.27	$16.25	+6.42%
— Q1 FY2023	Mar 31, 2023	—	$15.93	$15.27	-4.14%
— Q4 FY2022	Dec 31, 2022	—	$13.98	$15.60	+11.59%

Q1 FY2026+1.06%

Report Date

Mar 31, 2026

EPS Beat/Miss

—

Price Before

$6.59

Price After

$6.66

Q3 FY2023+8.09%

Report Date

Sep 30, 2023

EPS Beat/Miss

—

Price Before

$20.15

Price After

$21.78

Q2 FY2023+6.42%

Report Date

Jun 30, 2023

EPS Beat/Miss

—

Price Before

$15.27

Price After

$16.25

Q1 FY2023-4.14%

Report Date

Mar 31, 2023

EPS Beat/Miss

—

Price Before

$15.93

Price After

$15.27

Q4 FY2022+11.59%

Report Date

Dec 31, 2022

EPS Beat/Miss

—

Price Before

$13.98

Price After

$15.60

Beat Rate0 / 5 quarters

Largest Move+11.59% (Q4 FY2022)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

InnoCan Pharma Corporation (INNO.CN) most recently reported earnings on March 31, 2026 for Q1 FY2026, posting EPS of $-0.31 (in line with the analyst consensus of —).

Each quarter, investors track INNO.CN earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. INNO.CN revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

INNO.CN's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

INNO.CN earnings · 4 questions

InnoCan Pharma Corporation's next earnings report is expected around TBD. INNO.CN typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; INNO.CN historically reports after market close (AMC).

INNO.CN earnings datewhen is INNO.CN earningsINNO.CN next earnings datewhen does INNO.CN report earningsINNO.CN earnings calendar

▸ Source: FMP · InnoCan Pharma Corporation SEC filings · US GAAP · InnoCan Pharma Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 10, 2026